GNPX Competitors & Alternatives

Compare Genprex Inc with similar stocks in the same industry

Biotechnology

GNPX

Main Stock
$1.45
-13.17%
Tradestie Score
40
Market Cap
$7.59M
Analyst Upside
+417.2%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Drug Discovery Biotech Gene Therapy
Competitive Moat: None
Core Technology Stack: non-viral gene delivery system, Oncoprex
Major Customers 2
clinical trial sites oncology patients (future)
Critical Suppliers 2
CROs plasmid/viral vector manufacturers
Direct Ecosystem Rivals 3

Top Competitors

216 stocks in Biotechnology
Company Price Market Cap P/E Score Action
CLYM Climb Bio, Inc. Common Stock
$9.19
-0.97%
$133.50M - 42 Compare
SRZN Surrozen, Inc. Common
$28.46
-7.21%
$117.07M - 34 Compare
ANRO Alto Neuroscience Inc.
$25.37
-4.30%
$110.20M - 44 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.31
+0.76%
$84.52M - 40 Compare
IMMX Immix Biopharma, Inc. Common Stock
$6.96
-1.14%
$67.94M - 48 Compare
DARE Dare Bioscience, Inc. Common Stock
$0.41
-9.86%
$28.98M - 42 Compare
NNVC NanoViricides Inc.
$1.14
-2.56%
$25.10M - 43 Compare
CODX Co-Diagnostics, Inc. Common Stock
$0.13
-21.32%
$17.00M - 42 Compare
AIM AIM ImmunoTech Inc.
$0.11
-4.50%
$7.26M - 38 Compare
RKTO RKTO
$0.30
+6.11%
- - 46 Compare

Data updated: Nov 22, 2026 | Industry: Biotechnology (SIC 2834)

216 stocks in this industry